Dr. Klaudia U. Hunter, MD

  • Lowell, MA
  • Radiation oncologist
NPI1346498789PAC ID8628210770
Medicare services, 2024
2,029
Medicare patients, 2024
445
Part D claims, 2024
125
Publications
8
Clinical trials
3
Practice address
295 Varnum Avenue, Lowell, MA 01854
Practice phone
Call (978) 937-6000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Lowell General Hospital

Hospital · Lowell, Massachusetts

See all 6 affiliations

Find Dr. Hunter's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Klaudia U. Hunter is a radiation oncologist in Lowell, Massachusetts

Dr. Hunter practices at Lowell General Hospital in Lowell, Massachusetts, part of Tufts Medicine.

Dr. Hunter's NPI, 1346498789, was assigned on August 27, 2008. Dr. Hunter graduated from Illinois Medical College in 2006. Dr. Hunter holds California license A101597.

NPI and contact details
Medicare PAC ID
8628210770
NPI enumeration date
August 27, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(978) 937-6000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
46
Medical school graduation
2006

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Klaudia U. Hunter practices at Lowell General Hospital in Lowell, Massachusetts

Dr. Hunter's primary practice is Lowell General Hospital, at 295 Varnum Avenue, Lowell, MA 01854 in Middlesex County. The practice phone is (978) 937-6000.

Source: Dmand AI Affiliation Data

Dr. Klaudia U. Hunter is affiliated with 5 sites of care and 1 medical group

Dr. Hunter's primary practice is Lowell General Hospital in Lowell, Massachusetts, part of Tufts Medicine. Dr. Hunter is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Radiation Oncology Associates, PA. Dmand AI also links Dr. Hunter to 3 more hospitals, each named with a free account.

See all 6 affiliations for Dr. Hunter

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Klaudia U. Hunter's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hunter practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Lowell General HospitalAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Hunter practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Tufts Medicine and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Klaudia U. Hunter is one of 186 radiation oncologists in Massachusetts

Radiation oncology is Dr. Hunter's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Hunter is licensed in California.

Specialties and state licenses

  • Radiation oncology, CaliforniaPrimaryLicense A101597 · taxonomy 2085R0001X

Radiation oncologists near Dr. Hunter

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Klaudia U. Hunter billed Medicare for 2,029 services in 2024

CMS data shows 2,029 Medicare services from Dr. Hunter across 21 procedure codes in 2024, for 445 Medicare patients. Medicare paid $142,942 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 20242,029
Medicare patients445
Paid by Medicare$142,942
Procedure codes21

Dr. Hunter's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 1,3372024: 1,47010%
Other services
2023: 3182024: 28211%
Office and hospital visits
2023: 3172024: 27713%

Dr. Hunter compared with the Massachusetts median for radiation oncologists, 2024

  • Dr. Hunter
  • Massachusetts median
Medicare services
2,029vs 1,16175% above
Medicare patients
445vs 1732.6 times
Part D claims
25vs 26Close to median

Medians across 182 radiation oncologists in Massachusetts with Dmand AI profiles that report each measure.

Dr. Hunter's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Hunter

Need commercial claims for Dr. Hunter?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Hunter and other radiation oncologists in Massachusetts.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Klaudia U. Hunter treated 445 Medicare patients in 2024, average age 75

CMS counts 445 Medicare patients who saw Dr. Hunter in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have cancer, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hunter's median patient age at 69, with 61% women.

Medicare patients, 2024445
Average age75
Average risk score1.64
Also on Medicaid19%

Dr. Hunter's Medicare patients by age, 2024

Dr. Hunter's Medicare patients by sex, 2024

  • Women24455%
  • Men20145%

Chronic conditions among Dr. Hunter's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Arthritis38%
  5. Anxiety31%
  6. Chronic kidney disease30%
  7. Diabetes29%
  8. Ischemic heart disease27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Hunter's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women61%
  • Men38%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Klaudia U. Hunter wrote 125 Medicare Part D claims in 2024

In 2024, Dr. Hunter wrote 125 Medicare Part D claims for 58 patients. 90% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $1,386 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

Part D claims, 2024125
Drugs named by CMS2
Total drug cost$1,386
Part D patients58

Dr. Hunter's Part D claims by kind of drug, 2024

  • Generic112 claims90%
  • Brand-name13 claims10%

Dr. Hunter's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Hunter's Part D claims, 2024

  • Opioids11%14 of 125 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 412024: 2539%

Drugs named by CMS: 2 in 2024, 3 in 2023.

See all prescribing by Dr. Hunter

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Klaudia U. Hunter scored 75 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Hunter for performance year 2024, reported as part of a group. Dr. Hunter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hunter as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes
MIPS final score, 2024
75 of 100

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Hunter by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Klaudia U. Hunter has 8 publications on record

Dmand AI links 8 papers to Dr. Hunter, published from 2011 to 2013. 2013 was the busiest year, with 4. The most frequent topics are Chemoradiotherapy, Head and Neck Neoplasms and Oropharyngeal Neoplasms. Dr. Hunter has published most often in Int J Radiat Oncol Biol Phys. Dr. Hunter's most frequent co-authors are Douglas B. Chepeha, MD, Carol R. Bradford, MD and Scott Alan McLean, MD, PhD.

Papers8
Years published2011 to 2013

Dr. Hunter's papers by year, 2011 to 2013

Topics Dr. Hunter writes about most

  • Chemoradiotherapy
  • Head and Neck Neoplasms
  • Oropharyngeal Neoplasms
  • Radiotherapy Dosage
  • Radiotherapy, Intensity-Modulated
  • Radiotherapy Planning, Computer-Assisted
  • Antineoplastic Combined Chemotherapy Protocols
  • Deglutition Disorders

Dr. Hunter's most frequent co-authors

Recent publications by Dr. Hunter

See all 8 publications and co-authors

See who Dr. Hunter researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Hunter works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Klaudia U. Hunter has worked on 3 clinical trials

Dmand AI links Dr. Hunter to 3 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Cognitive Dysfunction and Breast Diseases. NRG Oncology sponsors the most, 3.

Clinical trials with Dr. Hunter by phase

  1. NonePhase 1: no trials
  2. NonePhase 2: no trials
  3. 1Phase 2/3: 1 trial
  4. 2Phase 3: 2 trials
  5. NonePhase 4: no trials

Conditions in Dr. Hunter's trials

  • Breast Neoplasms
  • Cognitive Dysfunction
  • Breast Diseases
  • Cognition Disorders

Investigators on the most trials with Dr. Hunter

Recent clinical trials with Dr. Hunter

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Klaudia U. Hunter received $19,683 in industry payments from 2018 to 2022

CMS Open Payments shows 12 general payments to Dr. Hunter from 2 drug and device companies from 2018 to 2022. Consulting fees make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $14,833.

General payments to Dr. Hunter by program year, 2018 to 2022

Companies that paid Dr. Hunter the most, 2018 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Hunter

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Klaudia U. Hunter graduated from Illinois Medical College

Dr. Hunter graduated from Illinois Medical College in 2006.

  1. Medical schoolIllinois Medical College

Source: Dmand AI Professional Profile Data

Sources for Dr. Klaudia U. Hunter's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Klaudia U. Hunter

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Klaudia U. Hunter's NPI number?

Dr. Klaudia U. Hunter's NPI number is 1346498789. It was assigned on August 27, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Klaudia U. Hunter?

Dr. Klaudia U. Hunter is a radiation oncologist in Lowell, Massachusetts. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Klaudia U. Hunter practice?

Dr. Hunter practices at 295 Varnum Avenue, Lowell, MA 01854. Dr. Hunter's primary practice is Lowell General Hospital in Lowell, Massachusetts, part of Tufts Medicine. Dmand AI also links Dr. Hunter to 3 hospitals.

What is Dr. Klaudia U. Hunter's office phone number?

The practice phone on file for Dr. Hunter is (978) 937-6000.

What is Dr. Klaudia U. Hunter's medical license number?

Dr. Hunter holds California license A101597.

Which hospitals is Dr. Klaudia U. Hunter affiliated with?

Dr. Hunter practices at Lowell General Hospital in Lowell, Massachusetts. Dr. Hunter is also affiliated with Beth Israel Deaconess Medical Center. Dmand AI links Dr. Hunter to 3 more hospitals.

What medical group is Dr. Klaudia U. Hunter part of?

Dr. Hunter is linked to Radiation Oncology Associates, PA.

Does Dr. Klaudia U. Hunter accept Medicare?

Yes. CMS data shows Dr. Hunter billed Medicare for 2,029 services in 2024, and Dr. Hunter accepts Medicare assignment.

Does Dr. Klaudia U. Hunter offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Hunter as offering telehealth services.

What is Dr. Klaudia U. Hunter's MIPS score?

Dr. Hunter's MIPS final score for performance year 2024 is 75 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Klaudia U. Hunter see?

CMS counts 445 Medicare patients who saw Dr. Hunter in 2024, with an average age of 75.

What services does Dr. Klaudia U. Hunter bill to Medicare?

In 2024, Dr. Hunter's most billed Medicare services were radiation oncology (77014), radiation oncology (77427) and radiation oncology (77300).

Where did Dr. Klaudia U. Hunter go to medical school?

Dr. Hunter graduated from Illinois Medical College in 2006.

What drugs does Dr. Klaudia U. Hunter prescribe most?

In 2024 Medicare Part D data, Dr. Hunter's most prescribed drugs by claims were Dexamethasone and Pilocarpine HCl.

Has Dr. Klaudia U. Hunter received payments from drug or device companies?

CMS Open Payments shows $19,683 in general payments to Dr. Hunter from 2 companies from 2018 to 2022. The largest total came from Boston Scientific Corporation.

How long has Dr. Klaudia U. Hunter been practicing?

Dr. Hunter graduated from medical school in 2006, 20 years ago.

Does Dr. Klaudia U. Hunter do research?

Dmand AI links 8 publications to Dr. Hunter, published from 2011 to 2013. Dr. Hunter has worked on 3 clinical trials.

Who does Dr. Klaudia U. Hunter publish with?

Dr. Hunter's most frequent co-authors are Douglas B. Chepeha, MD (3 shared papers), Carol R. Bradford, MD (2 shared papers) and Scott Alan McLean, MD, PhD (2 shared papers).

Selling to radiation oncology practices?

See radiation oncologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)